Latest News

View More

Latest Content

View More

June’s top news stories

AstraZeneca reports positive results from CASPIAN trial of Imfinzi AstraZeneca’s human monoclonal antibody Imfinzi (durvalumab) improved overall survival in the…

April’s top news stories

I-Mab and MorphoSys begin Phase III study of blood cancer drug Chinese clinical-stage biopharmaceutical company I-Mab Biopharma and German biotech…